pharmaceutical treatments

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Pharmaceutical Treatments

Challenges of New Pharmaceutical Treatments in Latin America – Clinical Trials in Latin America.

Latin America is a region that faces several challenges in the healthcare industry, especially when it comes to the adoption of new pharmaceutical treatments.

The high cost of drugs, poor access to healthcare facilities, lack of education about new treatments, and weak regulatory systems are some of the challenges that hinder the development and implementation of new pharmaceutical treatments in the region.

High cost of drugs:

One of the significant challenges faced by Latin American countries is the high cost of drugs.

This is due to several factors such as import taxes, currency exchange rates, and monopolistic pricing.

Pharmaceutical companies often have the power to set prices for their products, making them inaccessible to a large part of the population.

The cost of drugs is particularly high for those suffering from chronic conditions such as cancer, HIV, and diabetes, which require long-term treatments that can be financially draining for families.

Poor access to healthcare facilities:

Another significant challenge faced by Latin American countries is poor access to healthcare facilities.

Many people in the region live in rural areas, where healthcare facilities are scarce, and transportation is limited. Even in urban areas, access to healthcare facilities can be challenging due to overcrowding and underfunding.

This lack of access to healthcare facilities makes it difficult for people to receive proper medical care, including the latest pharmaceutical treatments.

Lack of education about new treatments:

Another challenge faced by Latin American countries is the lack of education about new treatments. This is particularly true for people living in rural areas or those with low levels of education.

Patients and their families may not have the necessary information to make informed decisions about their health, including the benefits and risks of new treatments.

This lack of education can lead to skepticism about new treatments, reducing their adoption and uptake.

pharmaceutical treatments

Weak regulatory systems:

Weak regulatory systems are another significant challenge in Latin America.

These systems are responsible for ensuring that new drugs are safe and effective, and they play a critical role in the development and implementation of new treatments.

However, regulatory systems in Latin America are often understaffed and underfunded, making it difficult to review and approve new treatments quickly.

This delay can result in patients having limited access to new treatments, causing delays in their care.


In conclusion, the challenges faced by Latin America in the adoption of new pharmaceutical treatments are many.

The high cost of drugs, poor access to healthcare facilities, lack of education about new treatments, and weak regulatory systems are all factors that hinder the development and implementation of new treatments.

To overcome these challenges, governments in the region need to invest in the healthcare industry, increase funding for regulatory agencies, and improve education about new treatments.

Additionally, pharmaceutical companies should consider the financial constraints faced by people in the region and develop pricing strategies that make their drugs more accessible to the broader population.

Finally, healthcare providers should work together to increase access to healthcare facilities, particularly in rural areas, and educate patients and their families about the benefits and risks of new treatments.

By addressing these challenges, Latin America can improve the health and wellbeing of its population and ensure that new pharmaceutical treatments are accessible to those who need them most.

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

pharmaceutical treatments

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
pharmaceutical treatments

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

pharmaceutical treatments

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

pharmaceutical treatments

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

pharmaceutical treatments

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

pharmaceutical treatments

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
pharmaceutical treatments

The Cohortias Team

pharmaceutical treatments

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

pharmaceutical treatments

Network & Partnerships